WO2023175702A1 - Prognosis management support system and prognosis management support method - Google Patents

Prognosis management support system and prognosis management support method Download PDF

Info

Publication number
WO2023175702A1
WO2023175702A1 PCT/JP2022/011496 JP2022011496W WO2023175702A1 WO 2023175702 A1 WO2023175702 A1 WO 2023175702A1 JP 2022011496 W JP2022011496 W JP 2022011496W WO 2023175702 A1 WO2023175702 A1 WO 2023175702A1
Authority
WO
WIPO (PCT)
Prior art keywords
prognosis
recommendation model
target patient
data
recommendation
Prior art date
Application number
PCT/JP2022/011496
Other languages
French (fr)
Japanese (ja)
Inventor
裕太郎 井山
将司 末崎
正典 篠原
Original Assignee
株式会社日立製作所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社日立製作所 filed Critical 株式会社日立製作所
Priority to PCT/JP2022/011496 priority Critical patent/WO2023175702A1/en
Publication of WO2023175702A1 publication Critical patent/WO2023175702A1/en

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance

Definitions

  • the present invention relates to a prognosis management support system and a prognosis management support method.
  • Regenerative medicine is a treatment method that rebuilds destroyed body tissues by transplanting cells that have been harvested and processed from humans. It is possible to apply regenerative medicine to reconstruct neural networks, which have traditionally been considered difficult to regenerate, and this may also restore functions lost due to damage to the central nervous system, etc. is being born.
  • transplantation does not immediately cure the disease; in order to regenerate tissue and restore function, it is necessary to properly manage the prognosis over several months to several years. In other words, during the prognosis period, patients need to continue appropriate medication and rehabilitation.
  • Patent Document 1 discloses a rehabilitation support system for preventing a decrease in motivation for rehabilitation. Specifically, the past patient most similar to the target patient is extracted, and the extracted past patient's observation history information is used to predict and output the target patient's future observation information.
  • tissue regeneration and functional recovery after transplantation hold the key to the success or failure of treatment, and individual patient differences have a large impact on the degree of tissue regeneration and functional recovery. Therefore, there is no guarantee that the optimal medication or rehabilitation for one patient will also be optimal for other patients. For this reason, currently, patient prognosis management has to rely on the experience and intuition of doctors and therapists.
  • a prognosis management support system that is an embodiment of the present invention is a prognosis management support system that supports prognosis actions including medication and rehabilitation of a target patient during a prognosis period, and includes: A standard recommendation model database constructed for each disease or disorder and registered with standard recommendation models defined by multivariate analysis formulas; comprising a recommendation model construction unit and a recommendation calculation unit, and an analysis unit that calculates recommendations regarding prognostic actions for the target patient from the target patient's prognosis management data;
  • the recommendation model construction unit creates an individual recommendation model in which weights for explanatory variables in the multivariate analysis formula of the standard recommendation model corresponding to the target patient's disease or disorder are updated using the target patient's prognosis management data,
  • the recommendation calculation unit calculates recommendations regarding prognostic actions for the target patient from the target patient's prognosis management data using a standard recommendation model or an individual recommendation model, During the target patient's prognosis period, the recommendation calculation unit calculates a recommendation using the individual
  • Outputs prognostic action recommendations that link medication and rehabilitation that are optimized for each patient, maximizing the effectiveness of treatment for a patient's disease or disorder.
  • FIG. 1 is a diagram showing an overall image of a prognosis management support system.
  • FIG. 2 is a functional block diagram of a prognosis management support system.
  • FIG. 3 is a diagram showing the hardware configuration of an analysis section. This is the overall processing flow for building a recommendation model. This is the construction flow of a standard recommendation model. This is a recommendation output flow.
  • This is the data structure of the patient database. This is the data structure of the medical database.
  • This is the data structure of the prognosis status database.
  • This is the data structure of the prognosis status database.
  • This is the data structure of the prognostic behavior database.
  • This is the data structure of the prognostic behavior database. This is the data structure of the case database.
  • FIG. 1 shows the overall picture of the prognosis management support system of this embodiment
  • FIG. 2 shows a functional block diagram of the prognosis management support system.
  • the prognosis management support system 100 is a system that quantitatively evaluates the patient's condition during the prognosis period and outputs prognostic action recommendations that are optimized for each patient according to the patient's condition and the degree of tissue regeneration and functional recovery. be.
  • prognosis actions patients who need to continue taking medication and rehabilitation (collectively referred to as prognosis actions) for a certain period of time for reasons such as restoring the function of organs treated with regenerative medicine etc.
  • Prognosis management refers to optimizing prognosis actions for patients during the period during which a doctor examines the patient (referred to as the prognosis period).
  • the treatment content is not limited to regenerative medicine, in the case of regenerative medicine, there are large individual differences in the progress of tissue regeneration and functional recovery, and it is possible to achieve high effectiveness by proposing medication instructions and rehabilitation instructions that are optimally related to the individual patient. You can expect it.
  • the prognosis management support system 100 will be explained with reference to FIGS. 1 and 2.
  • Basic information and medication information about the target patient are registered in the patient database 121 as patient information.
  • the database may be referred to as DB.
  • FIG. 7 shows the data structure of the patient DB 121.
  • Basic information and medication information are registered in the patient DB 121 for each patient ID that uniquely identifies a patient whose prognosis is to be managed (target patient).
  • Basic information includes information such as the patient's age, gender, height, weight, disease history, and allergies.
  • Medication information records the medication history and includes information such as drug name, administration period, and side effects.
  • FIG. 8 shows the data structure of the medical treatment DB 122.
  • medical examination information includes the medical examination method used by the doctor, the medical examination results, and the like. Diagnostic information includes the name of the disease diagnosed by the doctor, its condition, cause, etc.
  • the treatment information includes implementation details and schedules of treatments (surgeries, etc.) that require prognosis management.
  • prognostic state information is registered in the prognostic state database 123 and prognostic action information is registered in the prognostic action database 124.
  • the prognosis status information indicates the physical condition of the patient
  • the prognosis behavior information indicates the content of the patient's medication and rehabilitation.
  • the prognosis state DB 123 and the prognosis action DB 124 are collectively referred to as a prognosis database 125.
  • FIGS. 9A, 9B, and 10 show the data structure of the prognosis status DB 123.
  • 9A to 9B are examples of data tables in which objective evaluation values of prognostic conditions are registered
  • FIG. 10 is an example of a data table in which subjective evaluation values of prognostic conditions are registered.
  • the objective evaluation value is an evaluation of the patient's condition based on data quantified by the sensor. For example, by having a patient wear a wearable sensor, data regarding the patient's biological information can be collected non-invasively and continuously.
  • the prognosis state DB 123a shown in FIG. 9A the values of the digital biomarkers and wearable sensing data collected in this way, and the evaluation based thereon are registered.
  • the prognosis state DB 123b shown in FIG. 9B is another example of an objective evaluation value, and is obtained by quantifying and evaluating the patient's motion using 3D motion capture.
  • 3D motion capture values and evaluations based on them are registered.
  • FIG. 10 shows an example in which ADL (Activities of Daily Living) evaluation and ePRO (electronic Patient Reported Outcome) are registered as examples of subjective evaluation values of prognostic conditions.
  • the subjective evaluation value is an evaluation based on the senses of the observer, and although it varies depending on the individuality of the observer, it includes useful information that cannot be evaluated by a sensor.
  • ADL evaluation is an evaluation of whether a person is able to perform the minimum daily activities necessary for daily life, and the observation results (evaluation scores) by the therapist are registered here.
  • ePRO is a self-evaluation report directly input by the patient using a smartphone or the like.
  • FIGS. 11A and 11B show the data structure of the prognostic action DB 124.
  • FIG. 11A is an example of a data table in which medication information is registered among prognostic actions
  • FIG. 11B is an example of a data table in which rehabilitation information is registered among prognostic actions.
  • Medication information includes the type/name of the drug, amount, date and time of administration, side effects, etc.
  • Rehabilitation information includes the type/name of rehabilitation, intensity, implementation date and time, special notes at the time of rehabilitation, etc.
  • Data in the prognosis DB 125 is registered for each prognosis ID that uniquely identifies a prognosis state or prognosis action.
  • Patient information from the patient DB 121 (see Fig. 7), medical information (medical data) from the medical treatment DB 122 (see Fig. 8), and prognosis DB 125 (Figs. 9A, B, Fig. 10, Fig. 11A, B).
  • Prognosis information is input to the analysis section 101 via the data input section 120.
  • the recommendation calculation unit 103 of the analysis unit 101 uses the recommendation model to output prognostic actions (positive recommendations) recommended to the patient, and the recommendation model construction unit 102 creates a recommendation model based on the information used to output the recommendation. By updating , we build an individual recommendation model that makes optimized recommendations for patients.
  • a recommendation model trained using patient's individual information will be referred to as an "individual recommendation model,” and a recommendation model trained using patient's individual information will be referred to as an “individual recommendation model,” and a recommendation model that has not been trained using patient's individual information will be referred to as “individual recommendation model.”
  • the model is called the standard recommendation model.
  • similar case information of patients who have cases similar to the case of the target patient is stored in the case database 111.
  • the doctor extracts similar case information (similar case data) from the case DB 111 and sets prognostic actions (negative recommendations) that are prohibited for the patient. Note that it is possible to continuously accumulate evidence in the case DB 111 by adding data of target patients whose prognosis has been managed using this system after the prognosis management is completed.
  • the recommendation output unit 130 integrates the positive recommendation and the negative recommendation and outputs a recommendation for the patient.
  • the recommendation destination may be a doctor or a target patient. Further, the output recommendations are simultaneously recorded in the recommendation database 131.
  • FIG. 3 shows the hardware configuration of the analysis section 101.
  • the analysis unit 101 is an information processing device such as a server.
  • a CPU (processor) 201 a main storage device 202, an auxiliary storage device 203, an I/O interface 204, a network interface 205, and the like are communicably connected via a bus 206.
  • An input device 207 such as a keyboard or a pointing device, and an output device 208 such as a display or printer are connected to the I/O interface 204.
  • the function of the analysis unit 101 is that a program stored in an auxiliary storage device 203 is read into the main storage device 202 by a CPU (processor) 201 and executed, thereby performing a predetermined process in cooperation with other hardware. This will be realized.
  • a program executed by the information processing device, its function, or means for realizing the function are expressed as functional blocks such as the recommendation model construction unit 102 and the recommendation calculation unit 103 in FIG.
  • FIG. 4 shows the overall processing flow of recommendation model construction in the prognosis management support system 100.
  • the premise of this flow is that since the recommendation model in the prognosis management support system 100 is a statistical model, a certain amount of patient information for prognosis management has already been accumulated through demonstration experiments and trials, and based on that accumulation, the recommendation model is a statistical model.
  • a standard recommendation model corresponding to the disease or disorder has already been created and registered in the recommendation model database 110.
  • FIG. 13 shows the data structure of the recommendation model DB 110.
  • recommended model information such as analytical formulas is registered for each model ID that uniquely identifies a recommended model.
  • the doctor inputs the target patient's disease or disorder name into the analysis unit 101 (S01).
  • the analysis unit 101 searches the recommendation model DB 110 and checks whether there is a standard recommendation model for the input disease or disorder name (S02). If it does not exist, a standard recommendation model is constructed (S03) and registered in the recommendation model DB 110. The method for constructing the standard recommendation model will be described later.
  • the data input unit 120 inputs patient data, medical care data, and prognosis data regarding the target patient to the analysis unit 101.
  • the data input unit 120 not only inputs these data into the analysis unit 101 using a data input instruction from a doctor or the like as a trigger, but also inputs these data into the analysis unit 101 using a database update as a trigger or at a predetermined time. It is desirable to set it so that it is automatically entered.
  • the recommendation calculation unit 103 calculates proactive recommendations by substituting input data into a standard recommendation model.
  • the positive recommendation output by the standard recommendation model is a recommendation that recommends a prognostic action in which medication and rehabilitation are optimally associated for a standard patient, based on cases accumulated in the prognosis management support system 100.
  • the analysis unit 101 displays the calculated prognostic action recommendation to the doctor (S06).
  • the doctor can set so that an alert (recommendation for the target patient) is automatically sent as necessary.
  • the data input unit 120 inputs or automatically inputs prognosis data corresponding to the results of active recommendations into the analysis unit 101.
  • the recommendation model construction unit 102 checks whether an individual recommendation model for the target patient already exists (S08), and if it does not exist, registers an individual recommendation model for the target patient based on the standard recommendation model ( S09). Then, the individual recommendation model is updated using the active recommendation and the track record for the active recommendation as learning data (S10).
  • the framework of the individual recommendation model is the same as that of the standard recommendation model, but the weighting is optimized for the target patient.
  • the objective variables and explanatory variables are the same in the standard recommendation model and the individual recommendation model, but in the individual recommendation model, the coefficients a i (1 ⁇ i ⁇ n) and b in the multivariate analysis has been modified by learning based on prognostic data.
  • step S05 calculation of active recommendations using the individual recommendation model and updating of the individual recommendation model will be repeated until the target patient finishes using the solution of this system. That is, after inputting the first prognosis data, the calculation of the active recommendation in step S05 is executed using the individual recommendation model. Thereby, it is possible to make prognostic action recommendations optimized for each target patient.
  • the target patient's use of the solution of this system ends at the end of the prognosis period (S11). Thereafter, necessary anonymization processing is performed on the series of data of the target patient, and the standard recommendation model is updated as learning data (S12). This is to update the standard recommendation model based on the state of tissue regeneration and functional recovery at the end of the prognosis period.
  • FIG. 5 shows the construction flow of the standard recommendation model by the recommendation model construction unit 102 in step S03.
  • a standard recommendation model is created for each disease or disorder. Further, here, a case where a recommendation model is created using a multivariate analysis formula will be explained as an example.
  • target variable candidates are selected (S21-S22). For example, it is desirable to select objective data (sensing data) that reflects the disease status, tissue regeneration, and degree of functional recovery from prognostic data as the objective variable. For example, the amount of dopamine secretion is selected as a candidate variable of interest.
  • explanatory variable candidates are selected (S23-S24).
  • parameter factors that can influence the selected objective variable candidates are selected from patient data, medical care data, prognostic state data, and prognostic behavior data.
  • candidate explanatory variables include gender, age, blood type, height, weight, ADL score, pulse rate, blood pressure, heart rate, 3D motion capture data, type, timing, and amount of medication (time axis and intensity for each medication). ) Type, timing, and intensity of rehabilitation (time axis and intensity for each set).
  • the obtained multivariate analysis formula is greater than or equal to the accuracy index value, it is determined as a standard recommendation model (S30), and if the obtained multivariate analysis formula is less than the accuracy index value, the objective variable and explanatory variable are Start over with selection.
  • the standard recommendation model obtained in this way uses sensing data that reflects the target patient's condition (for example, dopamine secretion level) as the objective variable, and sets explanatory variables as input variables for the recommendation model (input explanatory variables) and output from the recommendation model.
  • This is a multivariate analysis formula in which the output explanatory variable is the output explanatory variable.
  • Input explanatory variables are appropriately selected variables that indicate the characteristics of the target patient obtained from patient data, the disease or disorder obtained from clinical data, the characteristics of the treatment content, the patient's prognostic state and prognostic behavior obtained from prognostic data.
  • the output explanatory variable is a variable indicating the content of the patient's prognosis action that is output as a positive recommendation.
  • FIG. 6 shows the flow for outputting recommendations to target patients.
  • FIG. 12 shows the data structure of the case DB 111.
  • case information is registered for each case ID that uniquely identifies a case.
  • the analysis unit 101 collates the patient data and medical care data of the target patient with the case data stored in the case DB 111, and extracts similar case data of the target patient (S41).
  • the analysis unit 101 outputs candidates for prohibited acts from the extracted similar case data (S42). For example, from the case data shown in FIG. 12, since a side effect of "dizziness during rehabilitation during high blood pressure" is observed, an action such as performing rehabilitation during high blood pressure can be output as a prohibited action.
  • the doctor sets prohibited actions and, if necessary, sets an automatic alert on the target patient's wearable sensor (S43). For example, a doctor should prohibit rehabilitation if the pulse exceeds 140 beats per minute, or if the systolic blood pressure during exercise increases by 40 mmHG or more, or if the diastolic blood pressure increases by 20 mmHG or more during exercise. If the target patient is wearing a wearable sensor, an alarm will be generated to the target patient to stop rehabilitation if the value of sensing data from the wearable sensor meets these conditions. Set. This makes it possible to ensure compliance with prohibited acts even when the patient is undergoing rehabilitation at home. Note that prohibited acts (negative recommendations) are not expected to change significantly unless the patient's condition changes significantly. Therefore, the setting of prohibited acts may be reviewed at an appropriate timing based on the doctor's judgment.
  • the data input unit 120 inputs the target patient's data set defined as an input explanatory variable in the recommendation model to the analysis unit 101 (S44).
  • the recommendation calculation unit 103 calculates a positive recommendation using the recommendation model (S45).
  • the recommendation model uses sensing data that reflects the condition of the target patient (for example, dopamine secretion level) as the objective variable, and uses the explanatory variables as input variables to the recommendation model and output from the recommendation model.
  • the data of the target patient is input to the input explanatory variable, and an output explanatory variable that makes the target variable a normal value is calculated.
  • the output explanatory variable is a variable that indicates the content of the patient's prognosis action.
  • prognostic actions such as the type, timing, and amount of medication (time axis and intensity for each drug), and rehabilitation type, timing, and intensity (time axis and intensity for each set) are output as the content of the recommendation.
  • FIG. 14 shows a GUI screen of the prognosis management support system 100.
  • the GUI screen 300 is a screen displayed to the doctor, and display contents can be selected using tabs 301.
  • the "recommendation tab" is shown open.
  • a summary of the patient's condition is displayed based on patient data, medical care data, and prognosis data, and recommendations made by the analysis unit 101 are also displayed. Active recommendations are displayed as recommended actions, and negative recommendations are displayed as prohibited actions.
  • FIG. 15 shows an example of an automatic alert for a patient using a wearable sensor. If a patient is wearing a wearable sensor to measure their physical condition, it is preferable that the wearable sensor generates an alarm, but automatic alerts can be sent to a device that the patient carries at all times, such as a smartwatch or smartphone. may be set. As shown in FIG. 15, notifications can be made in various situations.
  • FIG. 16 shows a modification of the prognosis management support system.
  • the recommendation model construction unit 102 constructs a standard recommendation model
  • the prognosis management support system 100b uses a standard recommendation model construction unit 402 that exclusively constructs a standard recommendation model. It has a model construction section 401.
  • a standard model construction unit 401 creates a standard recommendation model
  • a plurality of analysis units 501i (1 ⁇ i ⁇ m) calculate recommendations for target patients and create individual recommendation models.
  • the analysis unit 501i is installed in a server installed at each medical institution
  • the standard model construction unit 401 is installed in a server different from the analysis unit 501i.
  • the analysis unit 501i performs the same processing as the analysis unit 101 except for creating and updating the standard recommendation model.
  • the prognosis management database 512 is a collective term for the patient DB 121, the medical treatment DB 122, and the prognosis DB 125.
  • Prognosis management data of patients whose prognosis period has ended is anonymized and then provided to the standard model construction unit 401.
  • the standard recommendation model construction unit 402 creates and updates a standard recommendation model using anonymized prognosis management data collected from each analysis unit 501i stored in the prognosis management database 412. Further, the standard model construction unit 401 extracts case data from the prognosis management data accumulated in the prognosis management DB 412 and accumulates it in the case DB 411.

Abstract

A recommendation model building unit 102 creates an individual recommendation model in which prognostic management data for a target patient is used to update weightings for predictor variables in a multivariate analysis equation of a standard recommendation model corresponding to the disease or disorder of the target patient, a recommendation calculation unit 103 uses the standard recommendation model or the individual recommendations model to calculate recommendations regarding prognostic behavior for the target patient from the prognostic management data of the target patient, and, during the prognostic period of the target patient, the recommendation calculation unit calculates recommendations that use the individual recommendation model when an individual recommendation model has been created, and the recommendation model building unit uses the prognostic management data of the target patient that was used in calculating the recommendations to update the weightings of the predictor variables in the multivariate analysis equation of the individual recommendation model.

Description

予後管理支援システム及び予後管理支援方法Prognosis management support system and prognosis management support method
 本発明は、予後管理支援システム及び予後管理支援方法に関する。 The present invention relates to a prognosis management support system and a prognosis management support method.
 身体的機能の回復には、従来からリハビリテーションが行われてきた。再生医療は、ヒトから採取して加工した細胞を移植することで、一度破壊された身体組織を再建する治療法である。従来再生が難しいとされてきた神経ネットワークについても、再生医療を適用して神経ネットワークを再建することが可能であり、これにより、中枢神経の損傷等により失われた機能についても回復させられる可能性が生まれてきている。しかしながら、移植により直ちに治癒するわけではなく、組織を再生し、機能を回復させるためには、数か月から数年かけて予後管理を適切に行う必要がある。すなわち、予後期間において、患者は服薬とリハビリテーションを適切に継続すること必要がある。 Rehabilitation has traditionally been used to restore physical function. Regenerative medicine is a treatment method that rebuilds destroyed body tissues by transplanting cells that have been harvested and processed from humans. It is possible to apply regenerative medicine to reconstruct neural networks, which have traditionally been considered difficult to regenerate, and this may also restore functions lost due to damage to the central nervous system, etc. is being born. However, transplantation does not immediately cure the disease; in order to regenerate tissue and restore function, it is necessary to properly manage the prognosis over several months to several years. In other words, during the prognosis period, patients need to continue appropriate medication and rehabilitation.
 特許文献1は、リハビリテーションに対するモチベーションの低下を防止するためのリハビリ支援システムが開示されている。具体的には、対象患者と最も類似する過去患者を抽出し、抽出された過去患者の観察履歴情報を利用して、対象患者の将来の観察情報を予測して出力する。 Patent Document 1 discloses a rehabilitation support system for preventing a decrease in motivation for rehabilitation. Specifically, the past patient most similar to the target patient is extracted, and the extracted past patient's observation history information is used to predict and output the target patient's future observation information.
特開2016-197330号公報JP2016-197330A
 再生医療においては、移植してからの組織の再生、機能回復が治療の成否の鍵を握っており、患者それぞれの違いが組織の再生、機能回復の程度に与える影響も大きい。このため、ある患者に対して最適な投薬やリハビリテーションが他の患者にとっても最適なものであるという保証はない。このため、現状、患者の予後管理には、医師や療法士の経験や勘に頼らざるを得ないところがある。 In regenerative medicine, tissue regeneration and functional recovery after transplantation hold the key to the success or failure of treatment, and individual patient differences have a large impact on the degree of tissue regeneration and functional recovery. Therefore, there is no guarantee that the optimal medication or rehabilitation for one patient will also be optimal for other patients. For this reason, currently, patient prognosis management has to rely on the experience and intuition of doctors and therapists.
 このため、臨床現場における予後管理の意思決定が、担当医師個人や担当療法士個人の知見や経験に依存するところが大きく、人依存になりがちである。再生医療は現在も研究や試験が活発になされている先端医療分野であるため、エビデンスがそもそも十分に積みあがっていない症例もある。このため、細胞移植したものの最適な予後管理が実施されなかったために所期の治療効果を得られないことも起こりうる。 For this reason, decision-making regarding prognosis management in clinical settings largely depends on the knowledge and experience of individual physicians and therapists in charge, and tends to become person-dependent. Regenerative medicine is a cutting-edge medical field that is still actively researched and tested, so there are cases in which there is not enough evidence to begin with. Therefore, even if cells are transplanted, optimal prognosis management may not be carried out, and the expected therapeutic effect may not be obtained.
 このため、医師や患者に対して、過去の患者に対する投薬及びリハビリテーションの知見及び対象患者のデータを元に、最適な服薬及びリハビリテーションのレコメンドを出力し、患者の疾患や障害に対する治療効果の最大化を図ることが望まれる。 For this reason, we output recommendations for optimal medication and rehabilitation to doctors and patients based on past patient medication and rehabilitation knowledge and data on target patients, maximizing treatment effects for patients' diseases and disorders. It is desirable to aim for this.
 本発明の一実施の態様である予後管理支援システムは、予後期間における対象患者の服薬及びリハビリテーションを含む予後行為を支援する予後管理支援システムであって、
 疾患または障害ごとに構築され、多変量解析式により定義された標準レコメンドモデルが登録された標準レコメンドモデルデータベースと、
 レコメンドモデル構築部とレコメンド算出部とを備え、対象患者の予後管理データから対象患者に対する予後行為についてのレコメンドを算出する分析部とを有し、
 レコメンドモデル構築部は、対象患者の疾患または障害に対応する標準レコメンドモデルの多変量解析式の説明変数に対する重み付けを対象患者の予後管理データによって更新した個別レコメンドモデルを作成し、
 レコメンド算出部は、標準レコメンドモデルまたは個別レコメンドモデルを用いて、対象患者の予後管理データから対象患者に対する予後行為についてのレコメンドを算出し、
 対象患者の予後期間において、レコメンド算出部は個別レコメンドモデルが作成されている場合には個別レコメンドモデルを用いたレコメンドの算出を行い、レコメンドモデル構築部は、レコメンドの算出に用いた対象患者の予後管理データを用いて個別レコメンドモデルの多変量解析式の説明変数に対する重み付けを更新する。
A prognosis management support system that is an embodiment of the present invention is a prognosis management support system that supports prognosis actions including medication and rehabilitation of a target patient during a prognosis period, and includes:
A standard recommendation model database constructed for each disease or disorder and registered with standard recommendation models defined by multivariate analysis formulas;
comprising a recommendation model construction unit and a recommendation calculation unit, and an analysis unit that calculates recommendations regarding prognostic actions for the target patient from the target patient's prognosis management data;
The recommendation model construction unit creates an individual recommendation model in which weights for explanatory variables in the multivariate analysis formula of the standard recommendation model corresponding to the target patient's disease or disorder are updated using the target patient's prognosis management data,
The recommendation calculation unit calculates recommendations regarding prognostic actions for the target patient from the target patient's prognosis management data using a standard recommendation model or an individual recommendation model,
During the target patient's prognosis period, the recommendation calculation unit calculates a recommendation using the individual recommendation model if an individual recommendation model has been created, and the recommendation model construction unit calculates the prognosis of the target patient used to calculate the recommendation. Update the weighting of explanatory variables in the multivariate analysis formula of the individual recommendation model using management data.
 患者個人に最適化された服薬とリハビリテーションの関連付けがなされた予後行為レコメンドを出力し、患者の疾患や障害の治療効果の最大化を図る。 Outputs prognostic action recommendations that link medication and rehabilitation that are optimized for each patient, maximizing the effectiveness of treatment for a patient's disease or disorder.
 その他の課題と新規な特徴は、本明細書の記述および添付図面から明らかになるであろう。 Other objects and novel features will become apparent from the description of this specification and the accompanying drawings.
予後管理支援システムの全体像を示す図である。FIG. 1 is a diagram showing an overall image of a prognosis management support system. 予後管理支援システムの機能ブロック図である。FIG. 2 is a functional block diagram of a prognosis management support system. 分析部のハードウェア構成を示す図である。FIG. 3 is a diagram showing the hardware configuration of an analysis section. レコメンドモデル構築の全体処理フローである。This is the overall processing flow for building a recommendation model. 標準レコメンドモデルの構築フローである。This is the construction flow of a standard recommendation model. レコメンド出力フローである。This is a recommendation output flow. 患者データベースのデータ構造である。This is the data structure of the patient database. 診療データベースのデータ構造である。This is the data structure of the medical database. 予後状態データベースのデータ構造である。This is the data structure of the prognosis status database. 予後状態データベースのデータ構造である。This is the data structure of the prognosis status database. 予後状態データベースのデータ構造である。This is the data structure of the prognosis status database. 予後行為データベースのデータ構造である。This is the data structure of the prognostic behavior database. 予後行為データベースのデータ構造である。This is the data structure of the prognostic behavior database. 症例データベースのデータ構造である。This is the data structure of the case database. レコメンドモデルデータベースのデータ構造である。This is the data structure of the recommendation model database. 医師に対して表示される表示画面例である。This is an example of a display screen displayed to a doctor. ウェアラブルセンサによる患者に対する自動アラートの例である。This is an example of an automatic alert for a patient using a wearable sensor. 予後管理支援システムの変形例を示す図である。It is a figure which shows the modification of a prognosis management support system.
 図1に本実施例の予後管理支援システムの全体像を示し、図2に予後管理支援システムの機能ブロック図を示す。予後管理支援システム100は、予後期間における患者の状態を定量的に評価し、患者の容体や組織再生・機能回復の度合いに合わせて、患者個人に最適化された予後行為レコメンドを出力するシステムである。本実施例では、再生医療などによる治療を行った器官の機能を回復させる等の理由で、少なくとも服薬及びリハビリテーション(予後行為と総称する)を一定期間継続する必要のある患者を対象に、定期的に医師による診察が行われる期間(予後期間という)において、患者に対する予後行為の最適化を図ることを予後管理と呼んでいる。治療内容は再生医療に限定しないものの、再生医療の場合、組織再生や機能回復の進捗に個人差が大きく、患者個人に最適に関連付けられた服薬指示とリハビリテーション指示を提案することで、高い効果が期待できる。 FIG. 1 shows the overall picture of the prognosis management support system of this embodiment, and FIG. 2 shows a functional block diagram of the prognosis management support system. The prognosis management support system 100 is a system that quantitatively evaluates the patient's condition during the prognosis period and outputs prognostic action recommendations that are optimized for each patient according to the patient's condition and the degree of tissue regeneration and functional recovery. be. In this example, patients who need to continue taking medication and rehabilitation (collectively referred to as prognosis actions) for a certain period of time for reasons such as restoring the function of organs treated with regenerative medicine etc. Prognosis management refers to optimizing prognosis actions for patients during the period during which a doctor examines the patient (referred to as the prognosis period). Although the treatment content is not limited to regenerative medicine, in the case of regenerative medicine, there are large individual differences in the progress of tissue regeneration and functional recovery, and it is possible to achieve high effectiveness by proposing medication instructions and rehabilitation instructions that are optimally related to the individual patient. You can expect it.
 図1及び図2を参照しながら予後管理支援システム100について説明する。対象患者についての基本情報及び服薬情報が、患者情報として患者データベース121に登録されている。データベースを以下、DBと表記することがある。図7に患者DB121のデータ構造を示す。患者DB121には、予後管理される患者(対象患者)を一意に特定する患者IDごとに、基本情報と服薬情報とが登録されている。基本情報には、患者の年齢、性別、身長、体重、疾患歴、アレルギーなどの情報を含む。服薬情報には、服薬歴が記録されており、医薬品名、投与期間、副反応などの情報を含む。 The prognosis management support system 100 will be explained with reference to FIGS. 1 and 2. Basic information and medication information about the target patient are registered in the patient database 121 as patient information. Hereinafter, the database may be referred to as DB. FIG. 7 shows the data structure of the patient DB 121. Basic information and medication information are registered in the patient DB 121 for each patient ID that uniquely identifies a patient whose prognosis is to be managed (target patient). Basic information includes information such as the patient's age, gender, height, weight, disease history, and allergies. Medication information records the medication history and includes information such as drug name, administration period, and side effects.
 本システムによる予後管理支援が必要となった対象患者に対する医師による診察、診断、治療の診療情報は、診療データベース122に登録される。図8に診療DB122のデータ構造を示す。診療DB122は、医師による診療を一意に特定する診療IDごとに、診察情報、診断情報及び治療情報が登録されている。ここで、診療IDは患者IDとリンクされることにより、診療IDの登録内容がどの患者に対する診療情報であるか特定することができる。診察情報には、医師が診察したときの診察方法、診察結果などを含む。診断情報には医師が診断した疾患名、容体や原因などを含む。治療情報には、予後管理が必要になった治療(手術等)の実施内容やスケジュールなどを含む。 Medical information on examinations, diagnoses, and treatments by doctors for target patients who require prognosis management support by this system is registered in the medical care database 122. FIG. 8 shows the data structure of the medical treatment DB 122. In the medical treatment DB 122, medical examination information, diagnosis information, and treatment information are registered for each medical treatment ID that uniquely identifies medical treatment by a doctor. Here, by linking the medical care ID with the patient ID, it is possible to specify which patient the registered contents of the medical care ID correspond to. The medical examination information includes the medical examination method used by the doctor, the medical examination results, and the like. Diagnostic information includes the name of the disease diagnosed by the doctor, its condition, cause, etc. The treatment information includes implementation details and schedules of treatments (surgeries, etc.) that require prognosis management.
 予後期間においては、予後状態情報が予後状態データベース123に、予後行為情報が予後行為データベース124に登録される。ここで、予後状態情報は患者の身体状態を示すものであり、予後行為情報は患者の服薬、リハビリテーション内容を示すものである。予後状態DB123と予後行為DB124とを総称して予後データベース125という。予後DB125への入力は医師、療法士、患者の手入力で入力されるものもあるし、センシングデバイスから自動で入力されるものもある。 During the prognosis period, prognostic state information is registered in the prognostic state database 123 and prognostic action information is registered in the prognostic action database 124. Here, the prognosis status information indicates the physical condition of the patient, and the prognosis behavior information indicates the content of the patient's medication and rehabilitation. The prognosis state DB 123 and the prognosis action DB 124 are collectively referred to as a prognosis database 125. Some of the inputs to the prognosis DB 125 are manually input by a doctor, therapist, or patient, and some are automatically input from a sensing device.
 図9A、図9B及び図10に、予後状態DB123のデータ構造を示す。図9A~Bは、予後状態の客観的評価値を登録したデータテーブル例であり、図10は、予後状態の主観的評価値を登録したデータテーブル例である。客観的評価値は、センサにより数値化されたデータに基づく患者状態の評価である。例えば、患者にウェアラブルセンサを装着してもらい、非侵襲かつ継続的に患者の生体情報についてデータを収集することができる。図9Aに示す予後状態DB123aには、そのようにして収集したデジタルバイオマーカやウェアラブルセンシングデータの値、及びそれに基づく評価などが登録されている。図9Bに示す予後状態DB123bは客観的評価値の別の例であり、3Dモーションキャプチャを用いて、患者の動作を数値化して評価したものである。予後状態DB123bには、3Dモーションキャプチャの値、及びそれに基づく評価などが登録されている。図10には、予後状態の主観的評価値の例として、ADL(Activities of Daily Living)評価、ePRO(electronic Patient Reported Outcome)を登録した例を示している。主観的評価値は、観察者の感覚に基づく評価であり、観察者の個性によるばらつきはあるものの、センサでは評価できない有用な情報を含む。ADL評価とは日常生活を送るために最低限必要な日常動作ができているかの評価であり、ここでは療法士による観察結果(評価点数)が登録されている。ePROはスマートフォン等から患者が直接的に入力した自己評価報告である。 FIGS. 9A, 9B, and 10 show the data structure of the prognosis status DB 123. 9A to 9B are examples of data tables in which objective evaluation values of prognostic conditions are registered, and FIG. 10 is an example of a data table in which subjective evaluation values of prognostic conditions are registered. The objective evaluation value is an evaluation of the patient's condition based on data quantified by the sensor. For example, by having a patient wear a wearable sensor, data regarding the patient's biological information can be collected non-invasively and continuously. In the prognosis state DB 123a shown in FIG. 9A, the values of the digital biomarkers and wearable sensing data collected in this way, and the evaluation based thereon are registered. The prognosis state DB 123b shown in FIG. 9B is another example of an objective evaluation value, and is obtained by quantifying and evaluating the patient's motion using 3D motion capture. In the prognosis state DB 123b, 3D motion capture values and evaluations based on them are registered. FIG. 10 shows an example in which ADL (Activities of Daily Living) evaluation and ePRO (electronic Patient Reported Outcome) are registered as examples of subjective evaluation values of prognostic conditions. The subjective evaluation value is an evaluation based on the senses of the observer, and although it varies depending on the individuality of the observer, it includes useful information that cannot be evaluated by a sensor. ADL evaluation is an evaluation of whether a person is able to perform the minimum daily activities necessary for daily life, and the observation results (evaluation scores) by the therapist are registered here. ePRO is a self-evaluation report directly input by the patient using a smartphone or the like.
 図11A及び図11Bに、予後行為DB124のデータ構造を示す。図11Aは予後行為のうち投薬情報を登録したデータテーブル例であり、図11Bは予後行為のうちリハビリテーション情報を登録したデータテーブル例である。投薬情報として、薬の種類/名称、量、服薬日時、副反応等を含む。リハビリテーション情報として、リハビリテーションの種類/名前、強度、実施日時、リハビリテーション時の特記事項等を含む。 FIGS. 11A and 11B show the data structure of the prognostic action DB 124. FIG. 11A is an example of a data table in which medication information is registered among prognostic actions, and FIG. 11B is an example of a data table in which rehabilitation information is registered among prognostic actions. Medication information includes the type/name of the drug, amount, date and time of administration, side effects, etc. Rehabilitation information includes the type/name of rehabilitation, intensity, implementation date and time, special notes at the time of rehabilitation, etc.
 予後DB125のデータは、予後状態または予後行為を一意に特定する予後IDごとに登録されている。予後IDは、患者ID及び診療IDとリンクされることにより、予後DB125に登録された予後期間の状況が、どの患者のどの治療に基づくものであるか把握できるようになっている。 Data in the prognosis DB 125 is registered for each prognosis ID that uniquely identifies a prognosis state or prognosis action. By linking the prognosis ID with the patient ID and the medical treatment ID, it is possible to understand which treatment of which patient the status of the prognosis period registered in the prognosis DB 125 is based on.
 患者DB121(図7参照)からの患者情報(患者データ)、診療DB122(図8参照)からの診療情報(診療データ)、予後DB125(図9A,B、図10、図11A,B)からの予後情報(予後データ)はデータ入力部120を介して、分析部101に入力される。分析部101のレコメンド算出部103は、レコメンドモデルを用いて、患者に対し推奨する予後行為(積極的レコメンド)を出力するとともに、レコメンドモデル構築部102ではレコメンドの出力に用いた情報に基づきレコメンドモデルを更新することによって、患者に対して最適化されたレコメンドを行う個別レコメンドモデルを構築する。予後期間中、個別レコメンドモデルの学習を継続的に行うことにより、患者に最適化されたレコメンドを行うことが可能になる。以下では、レコメンドモデルが患者に対して最適化されているか否かを区別して示す場合には、患者の個別情報により学習がなされたレコメンドモデルを個別レコメンドモデル、患者の個別情報による学習前のレコメンドモデルを標準レコメンドモデルと呼ぶ。 Patient information (patient data) from the patient DB 121 (see Fig. 7), medical information (medical data) from the medical treatment DB 122 (see Fig. 8), and prognosis DB 125 (Figs. 9A, B, Fig. 10, Fig. 11A, B). Prognosis information (prognosis data) is input to the analysis section 101 via the data input section 120. The recommendation calculation unit 103 of the analysis unit 101 uses the recommendation model to output prognostic actions (positive recommendations) recommended to the patient, and the recommendation model construction unit 102 creates a recommendation model based on the information used to output the recommendation. By updating , we build an individual recommendation model that makes optimized recommendations for patients. By continuously learning the individual recommendation model during the prognosis period, it becomes possible to make recommendations optimized for the patient. In the following, when separately indicating whether a recommendation model is optimized for a patient, a recommendation model trained using patient's individual information will be referred to as an "individual recommendation model," and a recommendation model trained using patient's individual information will be referred to as an "individual recommendation model," and a recommendation model that has not been trained using patient's individual information will be referred to as "individual recommendation model." The model is called the standard recommendation model.
 一方、対象患者の症例と類似する症例をもつ患者の類似症例情報が症例データベース111に蓄積されている。医師は、症例DB111から類似症例情報(類似症例データ)を抽出し、患者に対して禁止する予後行為(消極的レコメンド)を設定する。なお、症例DB111には、本システムにより予後管理を行った対象患者のデータを予後管理終了後に追加していくことによって、エビデンスを継続的に蓄積していくことが可能とされている。 On the other hand, similar case information of patients who have cases similar to the case of the target patient is stored in the case database 111. The doctor extracts similar case information (similar case data) from the case DB 111 and sets prognostic actions (negative recommendations) that are prohibited for the patient. Note that it is possible to continuously accumulate evidence in the case DB 111 by adding data of target patients whose prognosis has been managed using this system after the prognosis management is completed.
 レコメンド出力部130は、積極的レコメンドと消極的レコメンドとを統合し、患者に対するレコメンドを出力する。レコメンド提供先は、後述するように医師とする場合と対象患者とする場合がある。また、出力されたレコメンドは、同時にレコメンドデータベース131に記録される。 The recommendation output unit 130 integrates the positive recommendation and the negative recommendation and outputs a recommendation for the patient. As described later, the recommendation destination may be a doctor or a target patient. Further, the output recommendations are simultaneously recorded in the recommendation database 131.
 図3に分析部101のハードウェア構成を示す。分析部101は、サーバなどの情報処理装置である。情報処理装置は、CPU(プロセッサ)201、主記憶装置202、補助記憶装置203、I/Oインタフェース204、ネットワークインタフェース205などがバス206により通信可能に接続されている。I/Oインタフェース204には、キーボードやポインティングデバイスのような入力装置207、ディスプレイやプリンタのような出力装置208が接続される。また、ネットワークインタフェース205を介して外部ネットワークと接続可能になる。分析部101の機能は、補助記憶装置203に格納されたプログラムがCPU(プロセッサ)201によって主記憶装置202に読み出され、実行されることで、定められた処理を他のハードウェアと協働して実現される。情報処理装置が実行するプログラム、その機能、あるいはその機能を実現する手段が、図2におけるレコメンドモデル構築部102、レコメンド算出部103といった機能ブロックとして表記されている。 FIG. 3 shows the hardware configuration of the analysis section 101. The analysis unit 101 is an information processing device such as a server. In the information processing device, a CPU (processor) 201, a main storage device 202, an auxiliary storage device 203, an I/O interface 204, a network interface 205, and the like are communicably connected via a bus 206. An input device 207 such as a keyboard or a pointing device, and an output device 208 such as a display or printer are connected to the I/O interface 204. Furthermore, it becomes possible to connect to an external network via the network interface 205. The function of the analysis unit 101 is that a program stored in an auxiliary storage device 203 is read into the main storage device 202 by a CPU (processor) 201 and executed, thereby performing a predetermined process in cooperation with other hardware. This will be realized. A program executed by the information processing device, its function, or means for realizing the function are expressed as functional blocks such as the recommendation model construction unit 102 and the recommendation calculation unit 103 in FIG.
 図4に予後管理支援システム100におけるレコメンドモデル構築の全体処理フローを示す。なお、本フローの前提として、予後管理支援システム100におけるレコメンドモデルは統計的モデルであるため、実証実験や試用を通じて予後管理する患者の情報が既にある程度の蓄積がなされ、その蓄積に基づいて、いくつかの疾患あるいは障害に対応する標準レコメンドモデルが既に作成され、レコメンドモデルデータベース110に登録されている。図13にレコメンドモデルDB110のデータ構造を示す。レコメンドモデルDB110は、レコメンドモデルを一意に特定するモデルIDごとに、解析式などのレコメンドモデル情報が登録されている。 FIG. 4 shows the overall processing flow of recommendation model construction in the prognosis management support system 100. The premise of this flow is that since the recommendation model in the prognosis management support system 100 is a statistical model, a certain amount of patient information for prognosis management has already been accumulated through demonstration experiments and trials, and based on that accumulation, the recommendation model is a statistical model. A standard recommendation model corresponding to the disease or disorder has already been created and registered in the recommendation model database 110. FIG. 13 shows the data structure of the recommendation model DB 110. In the recommended model DB 110, recommended model information such as analytical formulas is registered for each model ID that uniquely identifies a recommended model.
 医師は、対象患者の疾患または障害名を分析部101に入力する(S01)。分析部101は、レコメンドモデルDB110を検索し、入力された疾患または障害名の標準リコメンドモデルがあるかどうかを確認する(S02)。存在しない場合には、標準リコメンドモデルを構築し(S03)、レコメンドモデルDB110に登録する。標準リコメンドモデルの構築方法については後述する。 The doctor inputs the target patient's disease or disorder name into the analysis unit 101 (S01). The analysis unit 101 searches the recommendation model DB 110 and checks whether there is a standard recommendation model for the input disease or disorder name (S02). If it does not exist, a standard recommendation model is constructed (S03) and registered in the recommendation model DB 110. The method for constructing the standard recommendation model will be described later.
 標準リコメンドモデルが存在する場合、または標準リコメンドモデルの構築後、データ入力部120は、対象患者についての患者データ、診療データ、予後データを分析部101に入力する。データ入力部120は、医師等によるデータ入力指示をトリガとしてこれらのデータを分析部101に入力するだけでなく、データベースの更新をトリガにして、あるいは、所定の時刻でこれらのデータを分析部101に自動入力するように設定することが望ましい。 If a standard recommendation model exists or after the standard recommendation model is constructed, the data input unit 120 inputs patient data, medical care data, and prognosis data regarding the target patient to the analysis unit 101. The data input unit 120 not only inputs these data into the analysis unit 101 using a data input instruction from a doctor or the like as a trigger, but also inputs these data into the analysis unit 101 using a database update as a trigger or at a predetermined time. It is desirable to set it so that it is automatically entered.
 レコメンド算出部103は、標準レコメンドモデルに入力データを代入することにより、積極的レコメンドを算出する。標準レコメンドモデルが出力する積極的レコメンドは、予後管理支援システム100に蓄積された事例に基づき、標準的な患者について最適に服薬とリハビリテーションとが関連付けられた予後行為を推奨するレコメンドである。 The recommendation calculation unit 103 calculates proactive recommendations by substituting input data into a standard recommendation model. The positive recommendation output by the standard recommendation model is a recommendation that recommends a prognostic action in which medication and rehabilitation are optimally associated for a standard patient, based on cases accumulated in the prognosis management support system 100.
 分析部101は医師に算出した予後行為レコメンドを表示する(S06)。このとき、医師は、対象患者がウェアラブルセンサを装着している場合には、必要に応じてアラート(対象患者に対するレコメンド)を自動発信するよう、設定することができる。 The analysis unit 101 displays the calculated prognostic action recommendation to the doctor (S06). At this time, if the target patient is wearing a wearable sensor, the doctor can set so that an alert (recommendation for the target patient) is automatically sent as necessary.
 この後、対象患者についての予後データが予後データベース125に蓄積されることにより、積極的レコメンドに対する実績が得られる。データ入力部120は、積極的レコメンドに対する実績にあたる予後データを分析部101に入力または自動入力する。 Thereafter, the prognosis data for the target patient is accumulated in the prognosis database 125, thereby obtaining a track record for proactive recommendations. The data input unit 120 inputs or automatically inputs prognosis data corresponding to the results of active recommendations into the analysis unit 101.
 レコメンドモデル構築部102は、対象患者用の個別レコメンドモデルが既にあるか、確認し(S08)、存在しない場合には、標準レコメンドモデルを大元とする対象患者用の個別リコメンドモデルを登録する(S09)。そして、積極的レコメンドと積極的レコメンドに対する実績とを学習データとして個別レコメンドモデルをアップデートする(S10)。個別レコメンドモデルは、標準レコメンドモデルと骨格は変わらないが、重み付けが対象患者に対して最適化されている。例えば、標準レコメンドモデルが目的変数F、説明変数x(1≦i≦n)として、F=a+a+・・・+a+bのような多変量解析式で表される場合、標準レコメンドモデルと個別レコメンドモデルとで目的変数及び説明変数は同じであるが、個別レコメンドモデルでは、多変量解析式における係数a(1≦i≦n)、bが対象患者の予後データに基づく学習により変更されている。 The recommendation model construction unit 102 checks whether an individual recommendation model for the target patient already exists (S08), and if it does not exist, registers an individual recommendation model for the target patient based on the standard recommendation model ( S09). Then, the individual recommendation model is updated using the active recommendation and the track record for the active recommendation as learning data (S10). The framework of the individual recommendation model is the same as that of the standard recommendation model, but the weighting is optimized for the target patient. For example, the standard recommendation model is a multivariate analysis formula such as F=a 1 x 1 + a 2 x 2 +...+a n x n + b, where the objective variable is F and the explanatory variable x i (1≦i≦n). When expressed, the objective variables and explanatory variables are the same in the standard recommendation model and the individual recommendation model, but in the individual recommendation model, the coefficients a i (1≦i≦n) and b in the multivariate analysis has been modified by learning based on prognostic data.
 以降は、対象患者の本システムのソリューション利用が終了するまで、個別レコメンドモデルを用いた積極的レコメンドの算出、個別レコメンドモデルのアップデートが繰り返される。すなわち、最初の予後データの入力時以降は、ステップS05における積極的レコメンドの算出は個別レコメンドモデルを用いて実行される。これにより、対象患者ごとに最適化された予後行為レコメンドを行うことができる。 After that, calculation of active recommendations using the individual recommendation model and updating of the individual recommendation model will be repeated until the target patient finishes using the solution of this system. That is, after inputting the first prognosis data, the calculation of the active recommendation in step S05 is executed using the individual recommendation model. Thereby, it is possible to make prognostic action recommendations optimized for each target patient.
 対象患者の本システムのソリューション利用は、予後期間の終了により終了する(S11)。その後、対象患者の一連のデータに対して必要な匿名化処理を施し、学習データとして標準レコメンドモデルをアップデートする(S12)。予後期間を終えた時点での組織再生状況や機能回復状況を踏まえて、標準レコメンドモデルを更新するためである。 The target patient's use of the solution of this system ends at the end of the prognosis period (S11). Thereafter, necessary anonymization processing is performed on the series of data of the target patient, and the standard recommendation model is updated as learning data (S12). This is to update the standard recommendation model based on the state of tissue regeneration and functional recovery at the end of the prognosis period.
 図5にステップS03におけるレコメンドモデル構築部102による標準レコメンドモデルの構築フローを示す。標準レコメンドモデルは疾患または障害ごとに作成される。また、ここではレコメンドモデルを多変量解析式により作成する場合を例として説明する。 FIG. 5 shows the construction flow of the standard recommendation model by the recommendation model construction unit 102 in step S03. A standard recommendation model is created for each disease or disorder. Further, here, a case where a recommendation model is created using a multivariate analysis formula will be explained as an example.
 まず、目的変数候補を選択する(S21~S22)。目的変数には、例えば、予後状態データから疾患状況や組織再生、機能回復程度を反映する客観的データ(センシングデータ)を選択することが望ましい。例えば、目的変数候補としてドパミン分泌量を選択する。 First, target variable candidates are selected (S21-S22). For example, it is desirable to select objective data (sensing data) that reflects the disease status, tissue regeneration, and degree of functional recovery from prognostic data as the objective variable. For example, the amount of dopamine secretion is selected as a candidate variable of interest.
 続いて、説明変数候補を選択する(S23~S24)。説明変数には、選択した目的変数候補に対して影響を与えうるパラメータ因子を、患者データ、診療データ、予後状態データ、予後行為データの中から選択する。例えば、説明変数候補として、性別、年齢、血液型、身長、体重、ADL評価点数、脈拍数、血圧、心拍数、3Dモーションキャプチャデータ、服薬の種類、タイミング及び量(薬毎の時間軸と強度)リハビリテーションの種類、タイミング及び強度(セット別に時間軸と強度)などが挙げられる。 Next, explanatory variable candidates are selected (S23-S24). As explanatory variables, parameter factors that can influence the selected objective variable candidates are selected from patient data, medical care data, prognostic state data, and prognostic behavior data. For example, candidate explanatory variables include gender, age, blood type, height, weight, ADL score, pulse rate, blood pressure, heart rate, 3D motion capture data, type, timing, and amount of medication (time axis and intensity for each medication). ) Type, timing, and intensity of rehabilitation (time axis and intensity for each set).
 多変量解析の実行に十分なデータセット数があるか確認し(S25)、十分なデータセット数がある場合には、係数の値が決まっていない仮の多変量解析式を作成する(S26)。多変量解析には、一般に説明変数の数に対して、10倍以上のデータセット数が必要とされている。仮の多変量解析式にデータセットを入力し、標準偏回帰係数を求める(S27)。このようにして得られた多変量解析式が精度よく目的変数を推定できるものになっているかどうか検証するため、決定係数のような統計学指標を算出し(S28)、あらかじめ定めた精度指標値以上となっているか判定する(S29)。得られた多変量解析式が精度指標値以上であれば、標準レコメンドモデルとして決定し(S30)、得られた多変量解析式が精度指標値未満であれば、再度、目的変数、説明変数の選択からやり直す。 Check whether there is a sufficient number of data sets to perform multivariate analysis (S25), and if there is a sufficient number of data sets, create a temporary multivariate analysis formula with undetermined coefficient values (S26). . Multivariate analysis generally requires at least 10 times as many data sets as the number of explanatory variables. The data set is input into a temporary multivariate analysis formula, and standard partial regression coefficients are determined (S27). In order to verify whether the multivariate analysis formula obtained in this way can accurately estimate the target variable, statistical indicators such as the coefficient of determination are calculated (S28), and a predetermined accuracy index value is calculated. It is determined whether the above conditions are met (S29). If the obtained multivariate analysis formula is greater than or equal to the accuracy index value, it is determined as a standard recommendation model (S30), and if the obtained multivariate analysis formula is less than the accuracy index value, the objective variable and explanatory variable are Start over with selection.
 こうして得られる標準レコメンドモデルは、目的変数を対象患者の状態を反映するセンシングデータ(例えば、ドパミン分泌量)とし、説明変数をレコメンドモデルに対するインプットとなる変数(インプット説明変数)とレコメンドモデルからのアウトプットとなる変数(アウトプット説明変数)とする多変量解析式となる。インプット説明変数は、患者データから得られる対象患者の特徴、診療データから得られる疾患または障害、その治療内容の特徴、予後データから得られる患者の予後状態及び予後行為の内容を示す、適宜選択された変数であり、アウトプット説明変数は、積極的レコメンドとして出力される患者の予後行為の内容を示す変数である。 The standard recommendation model obtained in this way uses sensing data that reflects the target patient's condition (for example, dopamine secretion level) as the objective variable, and sets explanatory variables as input variables for the recommendation model (input explanatory variables) and output from the recommendation model. This is a multivariate analysis formula in which the output explanatory variable is the output explanatory variable. Input explanatory variables are appropriately selected variables that indicate the characteristics of the target patient obtained from patient data, the disease or disorder obtained from clinical data, the characteristics of the treatment content, the patient's prognostic state and prognostic behavior obtained from prognostic data. The output explanatory variable is a variable indicating the content of the patient's prognosis action that is output as a positive recommendation.
 図6に、対象患者に対し、レコメンドを出力するフローを示す。 FIG. 6 shows the flow for outputting recommendations to target patients.
 最初に対象患者に対する消極的レコメンドを決定する。このため、症例DB111を利用する。図12に症例DB111のデータ構造を示す。症例DB111は、症例を一意に特定する症例IDごとに症例情報が登録されている。分析部101は、対象患者の患者データ、診療データと症例DB111に蓄積された症例データとを照合して、対象患者の類似症例データを抽出する(S41)。分析部101は、抽出された類似症例データから禁止行為の候補を出力する(S42)。例えば、図12に示す症例データからは、「高血圧時にリハビリで目まい」という副作用がみられることから、高血圧時にリハビリテーションを行う、といった行為を禁止行為として出力することができる。 First, decide on a negative recommendation for the target patient. For this reason, the case DB 111 is used. FIG. 12 shows the data structure of the case DB 111. In the case DB 111, case information is registered for each case ID that uniquely identifies a case. The analysis unit 101 collates the patient data and medical care data of the target patient with the case data stored in the case DB 111, and extracts similar case data of the target patient (S41). The analysis unit 101 outputs candidates for prohibited acts from the extracted similar case data (S42). For example, from the case data shown in FIG. 12, since a side effect of "dizziness during rehabilitation during high blood pressure" is observed, an action such as performing rehabilitation during high blood pressure can be output as a prohibited action.
 医師は禁止行為を設定し、必要に応じて、対象患者のウェアラブルセンサに自動アラートを設定する(S43)。例えば、医師は、禁止行為として、「脈拍が140/分を超えた場合、または運動時収縮期血圧が40mmHG以上、運動時拡張期血圧が20mmHG以上上昇した場合において、リハビリテーションを行うこと」という内容を設定し、対象患者がウェアラブルセンサを身につけている場合には、ウェアラブルセンサによるセンシングデータの値がこれらの条件を満たした場合には、リハビリテーションを中止するよう、対象患者にアラームを発生するよう設定する。これにより、対象患者が在宅でリハビリテーションを行っているような場合であっても、禁止行為の遵守を徹底することが可能になる。なお、禁止行為(消極的レコメンド)は、患者の容体が大きく変化しない限り、大きく変化しないものと考えられる。したがって、禁止行為の設定は、医師の判断において適宜のタイミングで見直せばよい。 The doctor sets prohibited actions and, if necessary, sets an automatic alert on the target patient's wearable sensor (S43). For example, a doctor should prohibit rehabilitation if the pulse exceeds 140 beats per minute, or if the systolic blood pressure during exercise increases by 40 mmHG or more, or if the diastolic blood pressure increases by 20 mmHG or more during exercise. If the target patient is wearing a wearable sensor, an alarm will be generated to the target patient to stop rehabilitation if the value of sensing data from the wearable sensor meets these conditions. Set. This makes it possible to ensure compliance with prohibited acts even when the patient is undergoing rehabilitation at home. Note that prohibited acts (negative recommendations) are not expected to change significantly unless the patient's condition changes significantly. Therefore, the setting of prohibited acts may be reviewed at an appropriate timing based on the doctor's judgment.
 続いて、対象患者に対する積極的レコメンドを決定する。このため、データ入力部120は、レコメンドモデルにおいてインプット説明変数として定義されている対象患者のデータセットを分析部101に入力する(S44)。レコメンド算出部103は、レコメンドモデルを用いて積極的レコメンドを算出する(S45)。 Next, proactive recommendations for the target patient are determined. Therefore, the data input unit 120 inputs the target patient's data set defined as an input explanatory variable in the recommendation model to the analysis unit 101 (S44). The recommendation calculation unit 103 calculates a positive recommendation using the recommendation model (S45).
 例えば、レコメンドモデルが、上述したような、目的変数を対象患者の状態を反映するセンシングデータ(例えば、ドパミン分泌量)とし、説明変数をレコメンドモデルに対するインプットとなる変数とレコメンドモデルからのアウトプットとなる変数とする多変量解析式であるとする。インプット説明変数に対して、対象患者のデータを入力するとともに、目的変数を正常値とするようなアウトプット説明変数を算出する。アウトプット説明変数は、患者の予後行為の内容を示す変数である。具体的には、服薬の種類、タイミング及び量(薬毎の時間軸と強度)リハビリテーションの種類、タイミング及び強度(セット別に時間軸と強度)といった予後行為がレコメンドの内容として出力される。 For example, as described above, the recommendation model uses sensing data that reflects the condition of the target patient (for example, dopamine secretion level) as the objective variable, and uses the explanatory variables as input variables to the recommendation model and output from the recommendation model. Assume that it is a multivariate analytical formula with variables as follows. The data of the target patient is input to the input explanatory variable, and an output explanatory variable that makes the target variable a normal value is calculated. The output explanatory variable is a variable that indicates the content of the patient's prognosis action. Specifically, prognostic actions such as the type, timing, and amount of medication (time axis and intensity for each drug), and rehabilitation type, timing, and intensity (time axis and intensity for each set) are output as the content of the recommendation.
 図14に予後管理支援システム100のGUI画面を示す。GUI画面300は医師に対して表示される画面であり、表示内容がタブ301により選択可能とされている。ここでは「レコメンドタブ」を開いた状態を示している。患者データ、診療データ、予後状態データから患者の状態のサマリーが表示されるとともに、分析部101の実施したレコメンドが表示されている。積極的レコメンドが推奨行為として、消極的レコメンドが禁止行為として表示されている。 FIG. 14 shows a GUI screen of the prognosis management support system 100. The GUI screen 300 is a screen displayed to the doctor, and display contents can be selected using tabs 301. Here, the "recommendation tab" is shown open. A summary of the patient's condition is displayed based on patient data, medical care data, and prognosis data, and recommendations made by the analysis unit 101 are also displayed. Active recommendations are displayed as recommended actions, and negative recommendations are displayed as prohibited actions.
 図15にウェアラブルセンサによる患者に対する自動アラートの例を示している。患者が身体状態を測定するためにウェアラブルセンサを装着している場合には、ウェアラブルセンサによりアラームを発生させることが望ましいが、スマートウォッチやスマートフォンのような患者が常時携帯しているデバイスに自動アラートを設定してもよい。図15に示すように、様々なシチュエーションでの通知が考えられる。 FIG. 15 shows an example of an automatic alert for a patient using a wearable sensor. If a patient is wearing a wearable sensor to measure their physical condition, it is preferable that the wearable sensor generates an alarm, but automatic alerts can be sent to a device that the patient carries at all times, such as a smartwatch or smartphone. may be set. As shown in FIG. 15, notifications can be made in various situations.
 図16に予後管理支援システムの変形例を示す。上述した分析部101においては、レコメンドモデル構築部102が標準レコメンドモデルを構築していたのに対して、予後管理支援システム100bは、専ら標準レコメンドモデルを構築する標準レコメンドモデル構築部402を備える標準モデル構築部401を有する。実際のところ、医学的に未知な内容を含む症例から精度のよい標準レコメンドモデルを構築するには多数の症例を収集することが望ましい。そこで、予後管理支援システム100bは、標準モデル構築部401にて標準レコメンドモデルを作成し、複数の分析部501i(1<i≦m)において対象患者に対するレコメンドの算出と個別レコメンドモデルの作成を行う。例えば、分析部501iは医療機関ごとに設置されるサーバにそれぞれ実装され、標準モデル構築部401は分析部501iとは別のサーバに実装されている。 FIG. 16 shows a modification of the prognosis management support system. In the analysis unit 101 described above, the recommendation model construction unit 102 constructs a standard recommendation model, whereas the prognosis management support system 100b uses a standard recommendation model construction unit 402 that exclusively constructs a standard recommendation model. It has a model construction section 401. In fact, it is desirable to collect a large number of cases in order to construct an accurate standard recommendation model from cases that include medically unknown content. Therefore, in the prognosis management support system 100b, a standard model construction unit 401 creates a standard recommendation model, and a plurality of analysis units 501i (1<i≦m) calculate recommendations for target patients and create individual recommendation models. . For example, the analysis unit 501i is installed in a server installed at each medical institution, and the standard model construction unit 401 is installed in a server different from the analysis unit 501i.
 分析部501iでは標準レコメンドモデルの作成や更新以外については、分析部101と同様の処理を行う。なお、予後管理データベース512は、患者DB121、診療DB122、予後DB125の総称である。予後期間の終了した患者の予後管理データは、匿名化された上で、標準モデル構築部401にデータ提供される。標準レコメンドモデル構築部402では、予後管理データベース412に蓄積された各分析部501iから収集した、匿名化された予後管理データを用いて、標準レコメンドモデルの作成及び更新を行う。また、標準モデル構築部401では、予後管理DB412に蓄積された予後管理データから症例データを抽出し、症例DB411に蓄積する。 The analysis unit 501i performs the same processing as the analysis unit 101 except for creating and updating the standard recommendation model. Note that the prognosis management database 512 is a collective term for the patient DB 121, the medical treatment DB 122, and the prognosis DB 125. Prognosis management data of patients whose prognosis period has ended is anonymized and then provided to the standard model construction unit 401. The standard recommendation model construction unit 402 creates and updates a standard recommendation model using anonymized prognosis management data collected from each analysis unit 501i stored in the prognosis management database 412. Further, the standard model construction unit 401 extracts case data from the prognosis management data accumulated in the prognosis management DB 412 and accumulates it in the case DB 411.
100,100b:予後管理支援システム、101:分析部、102:レコメンドモデル構築部、103:レコメンド算出部、110:レコメンドモデルデータベース、111:症例データベース、120:データ入力部、121:患者データベース、122:診療データベース、123:予後状態データベース、124:予後行為データベース、125:予後データベース、130:レコメンド出力部、131:レコメンドデータベース、201:CPU、202:主記憶装置、203:補助記憶装置、204:I/Oインタフェース、205:ネットワークインタフェース、206:バス、207:入力装置、208:出力装置、300:GUI画面、301:タブ、401:標準モデル構築部、402:標準レコメンドモデル構築部、410:標準レコメンドモデルデータベース、411:症例データベース、412:予後管理データベース、501:分析部、502:個別レコメンドモデル構築部、510:個別レコメンドモデルデータベース、512:予後管理データベース。 100, 100b: Prognosis management support system, 101: Analysis unit, 102: Recommendation model construction unit, 103: Recommendation calculation unit, 110: Recommendation model database, 111: Case database, 120: Data input unit, 121: Patient database, 122 : Medical treatment database, 123: Prognosis state database, 124: Prognosis behavior database, 125: Prognosis database, 130: Recommendation output unit, 131: Recommendation database, 201: CPU, 202: Main storage device, 203: Auxiliary storage device, 204: I/O interface, 205: network interface, 206: bus, 207: input device, 208: output device, 300: GUI screen, 301: tab, 401: standard model construction section, 402: standard recommendation model construction section, 410: Standard recommendation model database, 411: case database, 412: prognosis management database, 501: analysis section, 502: individual recommendation model construction section, 510: individual recommendation model database, 512: prognosis management database.

Claims (14)

  1.  予後期間における対象患者の服薬及びリハビリテーションを含む予後行為を支援する予後管理支援システムであって、
     疾患または障害ごとに構築され、多変量解析式により定義された標準レコメンドモデルが登録された標準レコメンドモデルデータベースと、
     レコメンドモデル構築部とレコメンド算出部とを備え、前記対象患者の予後管理データから前記対象患者に対する予後行為についてのレコメンドを算出する分析部とを有し、
     前記レコメンドモデル構築部は、前記対象患者の疾患または障害に対応する標準レコメンドモデルの多変量解析式の説明変数に対する重み付けを前記対象患者の予後管理データによって更新した個別レコメンドモデルを作成し、
     前記レコメンド算出部は、標準レコメンドモデルまたは個別レコメンドモデルを用いて、前記対象患者の予後管理データから前記対象患者に対する予後行為についてのレコメンドを算出し、
     前記対象患者の予後期間において、前記レコメンド算出部は前記個別レコメンドモデルが作成されている場合には前記個別レコメンドモデルを用いたレコメンドの算出を行い、前記レコメンドモデル構築部は、レコメンドの算出に用いた前記対象患者の予後管理データを用いて前記個別レコメンドモデルの多変量解析式の説明変数に対する重み付けを更新する予後管理支援システム。
    A prognosis management support system that supports prognosis actions including medication and rehabilitation of a target patient during the prognosis period,
    A standard recommendation model database constructed for each disease or disorder and registered with standard recommendation models defined by multivariate analysis formulas;
    comprising a recommendation model construction unit and a recommendation calculation unit, and an analysis unit that calculates a recommendation regarding a prognostic action for the target patient from the prognosis management data of the target patient;
    The recommendation model construction unit creates an individual recommendation model in which weights for explanatory variables in a multivariate analysis formula of a standard recommendation model corresponding to a disease or disorder of the target patient are updated using prognosis management data of the target patient;
    The recommendation calculation unit calculates a recommendation regarding a prognostic action for the target patient from the prognosis management data of the target patient using a standard recommendation model or an individual recommendation model,
    During the prognosis period of the target patient, if the individual recommendation model has been created, the recommendation calculation unit calculates a recommendation using the individual recommendation model, and the recommendation model construction unit calculates a recommendation using the individual recommendation model. A prognosis management support system that updates weighting for explanatory variables in a multivariate analysis formula of the individual recommendation model using prognosis management data of the target patient.
  2.  請求項1において、
     前記予後管理データは、前記対象患者の特徴を示す患者データ、前記対象患者の疾患または障害、およびその治療の特徴を示す診療データ、予後期間における前記対象患者の身体状態を示す予後状態データ及び予後期間における前記対象患者の予後行為を示す予後行為データを含み、
     前記標準レコメンドモデルの多変量解析式の目的変数は、前記予後状態データから選択され、前記標準レコメンドモデルの多変量解析式の説明変数はインプット説明変数とアウトプット説明変数とからなり、前記インプット説明変数は前記患者データ、前記診療データ、前記予後状態データ及び前記予後行為データから選択され、前記アウトプット説明変数は前記予後行為データから選択され、
     前記レコメンド算出部は、前記対象患者の予後管理データを前記標準レコメンドモデルまたは前記個別レコメンドモデルの多変量解析式のインプット説明変数に入力し、目的変数が正常値となるアウトプット説明変数を算出する予後管理支援システム。
    In claim 1,
    The prognosis management data includes patient data indicating the characteristics of the target patient, medical data indicating the disease or disorder of the target patient and characteristics of its treatment, prognostic status data and prognosis indicating the physical condition of the target patient during the prognosis period. including prognostic behavior data indicating the prognostic behavior of the target patient during the period;
    The objective variable of the multivariate analysis formula of the standard recommendation model is selected from the prognosis status data, the explanatory variables of the multivariate analysis formula of the standard recommendation model include an input explanatory variable and an output explanatory variable, and the input explanatory variable The variables are selected from the patient data, the clinical data, the prognostic status data, and the prognostic behavior data, and the output explanatory variables are selected from the prognostic behavior data;
    The recommendation calculation unit inputs the prognosis management data of the target patient into an input explanatory variable of a multivariate analysis formula of the standard recommendation model or the individual recommendation model, and calculates an output explanatory variable that makes the objective variable a normal value. Prognosis management support system.
  3.  請求項2において、
     前記標準レコメンドモデルまたは前記個別レコメンドモデルの多変量解析式のアウトプット説明変数は、服薬の種類、時間軸並びに強度、及びリハビリテーションの種類、時間軸並びに強度を含む予後管理支援システム。
    In claim 2,
    The output explanatory variables of the multivariate analysis formula of the standard recommendation model or the individual recommendation model include the type, time axis, and intensity of medication, and the type, time axis, and intensity of rehabilitation.
  4.  請求項1において、
     過去の患者の疾患または障害、服薬実績及びリハビリテーション実績を登録した症例データベースを有し、
     前記分析部は、前記症例データベースを前記対象患者の予後管理データにより照合することにより、前記対象患者の類似症例データを抽出し、
     前記対象患者の類似症例データに基づき、前記対象患者の禁止行為が設定される予後管理支援システム。
    In claim 1,
    We have a case database that registers past patients' diseases or disabilities, medication records, and rehabilitation records.
    The analysis unit extracts similar case data of the target patient by comparing the case database with prognosis management data of the target patient,
    A prognosis management support system in which prohibited acts of the target patient are set based on similar case data of the target patient.
  5.  請求項1において、
     前記対象患者は、身体状態を計測するためのウェアラブルセンサを装着し、
     前記ウェアラブルセンサには前記分析部により算出されるレコメンドに基づく自動アラートが設定できる予後管理支援システム。
    In claim 1,
    The target patient wears a wearable sensor for measuring the physical condition,
    A prognosis management support system in which automatic alerts based on recommendations calculated by the analysis unit can be set in the wearable sensor.
  6.  請求項1において、
     予後管理支援システムにより予後行為を支援した患者の予後期間終了後に、当該患者の予後管理データを匿名化して蓄積する予後管理データベースと、
     前記予後管理データベースに蓄積された予後管理データを用いて前記標準レコメンドモデルを構築する標準レコメンドモデル構築部とを有する予後管理支援システム。
    In claim 1,
    A prognosis management database that anonymizes and accumulates prognosis management data of a patient whose prognosis action has been supported by the prognosis management support system after the prognosis period ends;
    A prognosis management support system comprising: a standard recommendation model construction unit that constructs the standard recommendation model using prognosis management data accumulated in the prognosis management database.
  7.  請求項6において、
     前記標準レコメンドモデル構築部と前記分析部とは異なるサーバに実装される予後管理支援システム。
    In claim 6,
    A prognosis management support system in which the standard recommendation model construction unit and the analysis unit are implemented on different servers.
  8.  予後期間における対象患者の服薬及びリハビリテーションを含む予後行為を支援する予後管理支援システムを用いた予後管理支援方法であって、
     前記予後管理支援システムは、疾患または障害ごとに構築され、多変量解析式により定義された標準レコメンドモデルが登録された標準レコメンドモデルデータベースと、レコメンドモデル構築部とレコメンド算出部とを備え、前記対象患者の予後管理データから前記対象患者に対する予後行為についてのレコメンドを算出する分析部とを有し、
     前記レコメンドモデル構築部は、前記対象患者の疾患または障害に対応する標準レコメンドモデルの多変量解析式の説明変数に対する重み付けを前記対象患者の予後管理データによって更新した個別レコメンドモデルを作成し、
     前記レコメンド算出部は、標準レコメンドモデルまたは個別レコメンドモデルを用いて、前記対象患者の予後管理データから前記対象患者に対する予後行為についてのレコメンドを算出し、
     前記対象患者の予後期間において、前記レコメンド算出部は前記個別レコメンドモデルが作成されている場合には前記個別レコメンドモデルを用いたレコメンドの算出を行い、前記レコメンドモデル構築部は、レコメンドの算出に用いた前記対象患者の予後管理データを用いて前記個別レコメンドモデルの多変量解析式の説明変数に対する重み付けを更新する予後管理支援方法。
    A prognosis management support method using a prognosis management support system that supports prognosis actions including medication and rehabilitation of a target patient during a prognosis period, the method comprising:
    The prognosis management support system is constructed for each disease or disorder and includes a standard recommendation model database in which a standard recommendation model defined by a multivariate analysis formula is registered, a recommendation model construction section, and a recommendation calculation section, an analysis unit that calculates recommendations regarding prognostic actions for the target patient from the patient's prognosis management data;
    The recommendation model construction unit creates an individual recommendation model in which weights for explanatory variables in a multivariate analysis formula of a standard recommendation model corresponding to a disease or disorder of the target patient are updated using prognosis management data of the target patient;
    The recommendation calculation unit calculates a recommendation regarding a prognostic action for the target patient from the prognosis management data of the target patient using a standard recommendation model or an individual recommendation model,
    During the prognosis period of the target patient, if the individual recommendation model has been created, the recommendation calculation unit calculates a recommendation using the individual recommendation model, and the recommendation model construction unit calculates a recommendation using the individual recommendation model. A prognosis management support method that updates weights for explanatory variables in a multivariate analysis formula of the individual recommendation model using prognosis management data of the target patient.
  9.  請求項8において、
     前記予後管理データは、前記対象患者の特徴を示す患者データ、前記対象患者の疾患または障害、およびその治療の特徴を示す診療データ、予後期間における前記対象患者の身体状態を示す予後状態データ及び予後期間における前記対象患者の予後行為を示す予後行為データを含み、
     前記標準レコメンドモデルの多変量解析式の目的変数は、前記予後状態データから選択され、前記標準レコメンドモデルの多変量解析式の説明変数はインプット説明変数とアウトプット説明変数とからなり、前記インプット説明変数は前記患者データ、前記診療データ、前記予後状態データ及び前記予後行為データから選択され、前記アウトプット説明変数は前記予後行為データから選択され、
     前記レコメンド算出部は、前記対象患者の予後管理データを前記標準レコメンドモデルまたは前記個別レコメンドモデルの多変量解析式のインプット説明変数に入力し、目的変数が正常値となるアウトプット説明変数を算出する予後管理支援方法。
    In claim 8,
    The prognosis management data includes patient data indicating the characteristics of the target patient, medical data indicating the disease or disorder of the target patient and characteristics of its treatment, prognostic status data and prognosis indicating the physical condition of the target patient during the prognosis period. including prognostic behavior data indicating the prognostic behavior of the target patient during the period;
    The objective variable of the multivariate analysis formula of the standard recommendation model is selected from the prognosis status data, the explanatory variables of the multivariate analysis formula of the standard recommendation model include an input explanatory variable and an output explanatory variable, and the input explanatory variable The variables are selected from the patient data, the clinical data, the prognostic status data, and the prognostic behavior data, and the output explanatory variables are selected from the prognostic behavior data;
    The recommendation calculation unit inputs the prognosis management data of the target patient into an input explanatory variable of a multivariate analysis formula of the standard recommendation model or the individual recommendation model, and calculates an output explanatory variable that makes the objective variable a normal value. Prognosis management support method.
  10.  請求項9において、
     前記標準レコメンドモデルまたは前記個別レコメンドモデルの多変量解析式のアウトプット説明変数は、服薬の種類、時間軸並びに強度、及びリハビリテーションの種類、時間軸並びに強度を含む予後管理支援方法。
    In claim 9,
    The output explanatory variables of the multivariate analysis formula of the standard recommendation model or the individual recommendation model include the type, time axis, and intensity of medication, and the type, time axis, and intensity of rehabilitation.
  11.  請求項8において、
     前記予後管理支援システムは、過去の患者の疾患または障害、服薬実績及びリハビリテーション実績を登録した症例データベースを有し、
     前記分析部は、前記症例データベースを前記対象患者の予後管理データにより照合することにより、前記対象患者の類似症例データを抽出し、
     前記対象患者の類似症例データに基づき、前記対象患者の禁止行為が設定される予後管理支援方法。
    In claim 8,
    The prognosis management support system has a case database in which past patients' diseases or disabilities, medication records, and rehabilitation records are registered,
    The analysis unit extracts similar case data of the target patient by comparing the case database with prognosis management data of the target patient,
    A prognosis management support method in which prohibited acts for the target patient are set based on similar case data of the target patient.
  12.  請求項8において、
     前記対象患者は、身体状態を計測するためのウェアラブルセンサを装着し、
     前記ウェアラブルセンサには前記分析部により算出されるレコメンドに基づく自動アラートが設定できる予後管理支援方法。
    In claim 8,
    The target patient wears a wearable sensor for measuring the physical condition,
    A prognosis management support method in which an automatic alert based on a recommendation calculated by the analysis unit can be set in the wearable sensor.
  13.  請求項8において、
     前記予後管理支援システムは、前記予後管理支援システムにより予後行為を支援した患者の予後期間終了後に、当該患者の予後管理データを匿名化して蓄積する予後管理データベースと、前記標準レコメンドモデルを構築する標準レコメンドモデル構築部とを有し、
     前記標準レコメンドモデル構築部は、前記予後管理データベースに蓄積された予後管理データを用いて、前記標準レコメンドモデルを構築する予後管理支援方法。
    In claim 8,
    The prognosis management support system includes a prognosis management database that anonymizes and accumulates the prognosis management data of the patient after the prognosis period of the patient whose prognosis behavior has been supported by the prognosis management support system, and a standard that constructs the standard recommendation model. It has a recommendation model construction department,
    In the prognosis management support method, the standard recommendation model construction unit constructs the standard recommendation model using prognosis management data accumulated in the prognosis management database.
  14.  請求項13において、
     前記標準レコメンドモデル構築部と前記分析部とは異なるサーバに実装される予後管理支援方法。
    In claim 13,
    A prognosis management support method in which the standard recommendation model construction unit and the analysis unit are implemented on a different server.
PCT/JP2022/011496 2022-03-15 2022-03-15 Prognosis management support system and prognosis management support method WO2023175702A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2022/011496 WO2023175702A1 (en) 2022-03-15 2022-03-15 Prognosis management support system and prognosis management support method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2022/011496 WO2023175702A1 (en) 2022-03-15 2022-03-15 Prognosis management support system and prognosis management support method

Publications (1)

Publication Number Publication Date
WO2023175702A1 true WO2023175702A1 (en) 2023-09-21

Family

ID=88022497

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/011496 WO2023175702A1 (en) 2022-03-15 2022-03-15 Prognosis management support system and prognosis management support method

Country Status (1)

Country Link
WO (1) WO2023175702A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007507814A (en) * 2003-10-07 2007-03-29 エンテロス・インコーポレーテッド Simulation of patient-specific results
JP2009533782A (en) * 2006-04-17 2009-09-17 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Personal prognostic modeling in medical planning
WO2019045637A2 (en) * 2017-08-28 2019-03-07 Agency For Science, Technology And Research A predictive analytics solution for personalized clinical decision support
JP2020144471A (en) * 2019-03-04 2020-09-10 学校法人東海大学 Prognosis prediction system, prognosis prediction programming device, prognosis prediction device, prognosis prediction method and prognosis prediction program

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007507814A (en) * 2003-10-07 2007-03-29 エンテロス・インコーポレーテッド Simulation of patient-specific results
JP2009533782A (en) * 2006-04-17 2009-09-17 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Personal prognostic modeling in medical planning
WO2019045637A2 (en) * 2017-08-28 2019-03-07 Agency For Science, Technology And Research A predictive analytics solution for personalized clinical decision support
JP2020144471A (en) * 2019-03-04 2020-09-10 学校法人東海大学 Prognosis prediction system, prognosis prediction programming device, prognosis prediction device, prognosis prediction method and prognosis prediction program

Similar Documents

Publication Publication Date Title
RU2630122C2 (en) Method for continuous forecasting of disease severity, death and hospitalization duration
JP6466422B2 (en) Medical support system and method
WO2019008798A1 (en) Disease onset prediction device, disease onset prediction method, and program
KR20190132290A (en) Method, server and program of learning a patient diagnosis
WO2018106481A1 (en) Computer-implemented methods, systems, and computer-readable media for diagnosing a condition
CN111899837A (en) Operation report coordination method and system based on digital operating room
Zhu et al. Quantifying discordance between structure and function measurements in the clinical assessment of glaucoma
JP2018534697A (en) System and method for facilitating health monitoring based on personalized predictive models
US20230079951A1 (en) System for configuring patient monitoring
WO2023175702A1 (en) Prognosis management support system and prognosis management support method
WO2020050065A1 (en) Systems and methods for predicting recovery of a patient
JP2021039683A (en) Medical care assistance method, medical care assisting system, learning model generation method, and medical care assisting program
CN115602312A (en) Postoperative rehabilitation scheme generation method and device, electronic equipment and storage medium
KR101808836B1 (en) Learning apparatus, learning system, and learning method for using the same
CN113171059A (en) Postoperative END risk early warning of multi-modal monitoring information and related equipment
Ferrara et al. Infrastructure for data management and user centered rehabilitation in Rehab@ Home project
MAGWILI et al. Raspberry pi-based medical expert system for pre-diagnosis of mosquito-borne diseases
WO2024024317A1 (en) Computer program, information processing device, information processing method, and learning model generation method
JP7383245B1 (en) Depression risk determination system using fundus images, machine learning model generation device, depression risk determination device, and depression risk determination method
KR102357041B1 (en) Method for Analyzing and Predicting Disease by Using Artificial Intelligence
Alroughi et al. 1 Use of the modified early warning score (MEWS) to predict MICU readmission
US20230293103A1 (en) Analysis device
KR102522172B1 (en) Clinical linkage analysis system of subjective pain through voice analysis for pre-interview
Kyriacou et al. Post cardiac surgery home-monitoring system
JP7084861B2 (en) Evaluation processing system and evaluation processing method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22931987

Country of ref document: EP

Kind code of ref document: A1